[Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].

In aspirin-treated patients with acute coronary syndromes without ST-segment elevation unfractionated heparin (UFH) or low molecular weight heparin (LMWH) treatment < 7 days significantly reduce the risk of acute myocardial infarction (AMI), and LMWH furthermore reduces revascularisation. There is a non-significant effect on mortality compared with placebo and an insignificantly increased risk of haemorrhagic complications. No net clinical benefit of LMWH was found compared to UHF, but LMWH has pharmacokinetic advantages.

[Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].

In aspirin-treated patients with acute coronary syndromes without ST-segment elevation unfractionated heparin (UFH) or low molecular weight heparin (LMWH) treatment < 7 days significantly reduce the risk of acute myocardial infarction (AMI), and LMWH furthermore reduces revascularisation. There is a non-significant effect on mortality compared with placebo and an insignificantly increased risk of haemorrhagic complications. No net clinical benefit of LMWH was found compared to UHF, but LMWH has pharmacokinetic advantages.

[Superficial thrombophlebitis. Etiology, diagnosis and treatment].

Superficial thrombophlebitis is a common disease. Recently, a relatively high incidence of concomitant venous thromboembolism has been found. Graduated compressing stockings and low-molecular heparin subcutaneously in weight-based therapeutic doses for 10-30 days are considered the best treatment.

[Deep venous thrombosis--epidemiology, diagnosis and treatment].

The pathogenesis of deep vein thrombosis (DVT) involves vascular changes or injury, stasis and alterations in the blood composition. The risk increases with age; however, important risk factors are cancer, surgery, immobilisation and hormone therapy. DVT most often appears in the crural veins.

[Clopidogrel: background information and use in clinical practice].

Acute manifestations of atherosclerosis, e.g. myocardial infarction and ischaemic stroke, are among the most common causes of death in the western part of the world.